APA (7th ed.) Citation

AM, G., N, T., GJ, L., & E, S. (2022). Reply to: "Overlapping Ranges in Levels Indicate That Hexosylsphingosine Is Not a Clinically Relevant Biomarker for GBA1-Associated Parkinson's Disease". Movement disorders : official journal of the Movement Disorder Society, 37(8), 1781. https://doi.org/10.1002/mds.29131

Chicago Style (17th ed.) Citation

AM, Gleason, Tayebi N, Lopez GJ, and Sidransky E. "Reply to: "Overlapping Ranges in Levels Indicate That Hexosylsphingosine Is Not a Clinically Relevant Biomarker for GBA1-Associated Parkinson's Disease"." Movement Disorders : Official Journal of the Movement Disorder Society 37, no. 8 (2022): 1781. https://doi.org/10.1002/mds.29131.

MLA (9th ed.) Citation

AM, Gleason, et al. "Reply to: "Overlapping Ranges in Levels Indicate That Hexosylsphingosine Is Not a Clinically Relevant Biomarker for GBA1-Associated Parkinson's Disease"." Movement Disorders : Official Journal of the Movement Disorder Society, vol. 37, no. 8, 2022, p. 1781, https://doi.org/10.1002/mds.29131.